Pfizer Inc $30.45

up +0.10


22/7/2014 09:44 AM  |  NYSE : PFE  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get PFE Trend Analysis - it has underperformed the S&P 500 by 12%

Partner Headlines

  1. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  2. UPDATE: Pfizer Announces Purchase of InnoPharma for $225M Upfront Payment, ...

    Benzinga
  3. Will Congress Block Tax Inversions?

    FoxBusiness
  4. UPDATE: Pfizer Shares Higher After Finding Statistically Significant Reduction ...

    Benzinga
  5. Top 4 Mid-Cap Stocks In The Oil & Gas Refining & Marketing Industry With ...

    Benzinga
  6. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  7. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  8. Job or Invest: Growth Often Equals Happiness

    YCharts
  9. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  10. Jazz, Novo Among Medicals Showing Healthy Action

    IBD
  11. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  12. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  13. Barclays Increases Pfizer Price Target

    Benzinga
  14. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  15. Guru Favorites Top GuruFocus Dividend Growers of the Weeks

    GuruFocus
  16. Guru Favorites Top GuruFocus Dividend Growers of the Week

    GuruFocus
  17. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  18. #PreMarket Primer: Monday, June 30: U.S. Data To Confirm Second Quarter ...

    Benzinga
  19. Pfizer and others get EU nods

    IBD
  20. Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods

    IBD
  21. Pfizer, Bristol-Myers Squibb Announce Positive Opinion For Treatments

    Benzinga
  22. S&P: Cut Corporate Taxes to Create 10M New Jobs

    FoxBusiness
  23. Parexel Defended After Post-Guidance Sell-Off

    IBD
  24. Rumor Of Massive Monsanto-Syngenta Deal Gets Agriculture Sector Moving

    Benzinga
  25. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  26. Cubist Readies For Takeoff With New Antibiotic Launch

    IBD
  27. US Stock Futures Edge Higher; All Eyes On Fed Decision

    Benzinga
  28. Key Metric Makes Case For Stocks Over Bonds

    YCharts
  29. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  30. Market Wrap For June 16: M&A Frenzy Keep Indices In Positive Territory

    Benzinga
  31. Medtronic to Buy Covidien for $42.0 Billion

    FoxBusiness
  32. Dividends, Strength, Late-Bull-Market Performance

    YCharts
  33. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  34. Screening Stock Buybacks Against Liquidity

    YCharts
  35. Lannett Tops Trio Of Medical Small Cap Leaders

    IBD
  36. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  37. M&A Activity Fearless Against Rate Hikes

    FoxBusiness
  38. Dividend Stocks Vs. Junk Bond Yields

    YCharts
  39. AstraZeneca sees deal hurdles

    IBD
  40. A Bitter Pill

    FoxBusiness
  41. R&D Tax Credit Passed In The House, Faces Challenges Ahead

    Benzinga
  42. Allergan May Get Higher Bid

    IBD
  43. AstraZeneca Would Weigh Strong Pfizer Offer

    FoxBusiness
  44. 7 Stocks For Your Retirement Portfolio

    Benzinga
  45. Wall Street Edges Up, Builds on Record Highs

    FoxBusiness
  46. Stock Futures Up Ahead of Retail Sales Reading

    FoxBusiness
  47. #PreMarket Primer: Tuesday, May 13: Moscow Gives No Response To Donetsk's ...

    Benzinga
  48. Allergan Rejects Valeant Bid

    IBD
  49. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  50. Pfizer Defends AstraZeneca Deal

    FoxBusiness
Trading Center